96 related articles for article (PubMed ID: 15850509)
1. [Anti-HBV effect of fusion protein (TA1-IFN) in vitro].
Lu NF; Huang AL; Zheng RQ; Zhu YB; Xia ZF; Tang N; Yan G; Gao XL; Wu Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):252-4. PubMed ID: 15850509
[TBL] [Abstract][Full Text] [Related]
2. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
3. [Construction and expression of humanized anti-HBsAg scFv targeting interferon-alpha in escherichia coli].
Xia X; Cheng J; Yang J; Zhong Y; Wang G; Fang H; Liu Y; Li K; Dong J
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):28-30. PubMed ID: 11856497
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the replication of hepatitis B virus in vitro by emodin.
Shuangsuo D; Zhengguo Z; Yunru C; Xin Z; Baofeng W; Lichao Y; Yan'an C
Med Sci Monit; 2006 Sep; 12(9):BR302-6. PubMed ID: 16940925
[TBL] [Abstract][Full Text] [Related]
5. The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo.
Zhang Y; Wu Y; Ye S; Wang T; Zhao R; Chen F; Abe K; Jin X
Virus Res; 2013 Jan; 171(1):65-70. PubMed ID: 23123214
[TBL] [Abstract][Full Text] [Related]
6. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
Zhong XH; Deng X; Chen XC; Zhou BP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
[TBL] [Abstract][Full Text] [Related]
8. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
9. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
Akhan SC; Yulugkural Z; Vahaboglu H
Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
11. Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells.
Moshier JA; Mutchnick MG; Dosescu J; Holtz TK; Akkary S; Mahakala K; Merline JR; Naylor PH
J Hepatol; 1996 Dec; 25(6):814-20. PubMed ID: 9007707
[TBL] [Abstract][Full Text] [Related]
12. [Expression and activity analysis of interferonalpha-con and thymosin-alpha1].
Liu X; Liu F; Li B; Zhou H; Wang Q
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1168-73. PubMed ID: 18837390
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.
Andreone P; Cursaro C; Gramenzi A; Margotti M; Ferri E; Talarico S; Biselli M; Felline F; Tuthill C; Martins E; Gasbarrini G; Bernardi M
J Viral Hepat; 2001 May; 8(3):194-201. PubMed ID: 11380797
[TBL] [Abstract][Full Text] [Related]
14. Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha.
Ma JC; Wang LW; Li XJ; Liao YF; Hu XY; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):166-71. PubMed ID: 17374576
[TBL] [Abstract][Full Text] [Related]
15. [Expression of human anti-HBsAg-interferon fusion protein in CHO cells].
Tong Y; Wang H; Xu J; Fu L; Yu C; Liu G
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):114-6. PubMed ID: 11350695
[TBL] [Abstract][Full Text] [Related]
16. Thymosin alpha-1.
Ancell CD; Phipps J; Young L
Am J Health Syst Pharm; 2001 May; 58(10):879-85; quiz 886-8. PubMed ID: 11381492
[TBL] [Abstract][Full Text] [Related]
17. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
20. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
